New gel implant offers hope for back pain sufferers
NCT ID NCT04984629
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device called the HYDRAFIL system for people with long-term low back pain from worn-out spinal discs. 35 adults who had not gotten better with standard treatments received the implant. The main goal was to see if the device could be safely placed and help reduce pain and improve daily function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
35 people
The number who actually took part.
- Started
-
Jan 2022
- Finished
-
Oct 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Present with predominant low back pain and symptoms of DDD of the lumbar region of at least 6 months duration * Failure to have their symptoms resolve or reduce following 6 months conservative care (pain medication and/or physical therapy) * Male or female patients aged 22 to 80 years, inclusive * Presence of DDD on magnetic resonance imaging (MRI) scan with global disc degeneration. Modified Pfirrmann grades 5 to 8 as characterized by MRI * The presence of one or two symptomatic discs exhibiting degeneration contained within a competent outer annulus as determined by MRI and provocative discography and/or anaesthetic discography at L1-S1 * Patients who are legally competent and able to understand the nature, scope and aim of the clinical investigation * Signed an informed subject consent form in a language in which they are fluent Exclusion Criteria: * History of or current systemic or local infection * Annular tear or defect that shows free contrast extravasation into the epidural space during or after discography * Presence of disc herniation that accounts for the majority of the patient's symptoms * Subjects with Modic type 3 changes * Subjects with trans-endplate disc herniations or Schmorl's nodes * Neurogenic claudication due to spinal stenosis * Previous back surgery at the target level of the lumbar spine * Evidence of severe compression of cauda equina * Spinal segmental instability (spondylolysis or spondylolisthesis: Grade \>1), spinal canal stenosis, isthmus pathology, scoliosis \[Cobb angle \>20 at the incident level\] and other deformity conditions that may compromise the study * Subjects with arachnoiditis * Subjects who are prisoners or wards of the courts * Subjects involved in active litigation including worker's compensation cases * Subjects with low back pain of non-spinal or unknown etiology * Subjects with severe osteoporosis or metabolic bone disease * Subjects who have a history of or are current abusers of alcohol or drugs (using definition criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-V)) * If female, patients who are pregnant or are trying to become pregnant during the course of the trial. (due to risks of additional radiation exposures) * Failure to understand informed consent or participation in any other clinical study * Body Mass index (BMI) greater than 40 * Patients with active tumors in the spinal region * Patients who have been diagnosed to diabetes mellitus * Patients who have a sensitivity or allergy to the implant materials
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Degenerative disc disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beam Interventional & Diagnostic Imaging
Calgary, Alberta, T3K6G4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A conversation before spine surgery could change how patients recover
- Can a new bone graft match the gold standard for spinal fusion?
- Can a nanotube surface help spinal bones fuse faster?
- Can a growth factor from donor bone improve spinal fusion?
- 3D-Printed spinal cages could revolutionize back surgery
- Bone scan may help avoid unnecessary back surgery